Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2140790

CCCC[SiH](CCCC)CCCC.Cl

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.43
LMNA P02545 3/20 0.43
ALDH1A1 P00352 3/20 0.41
THRB P10828 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
DNM1 Q05193 6/20 0.35
TDP1 Q9NUW8 1/20 0.33
SLC22A1 O15245 2/20 0.32
SLC22A2 O15244 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL153638 0.96 TSHR (0.46) TSHRLMNAALDH1A1THRBSMN1; SMN2
SCHEMBL28217587 0.92 TSHR (0.43) TSHRLMNAALDH1A1THRBSMN1; SMN2
SCHEMBL706848 0.92 TSHR (0.43) TSHRLMNAALDH1A1THRBSMN1; SMN2
SCHEMBL704491 0.92 TSHR (0.43) TSHRLMNAALDH1A1THRBSMN1; SMN2
Bromide SCHEMBL31547794 0.92 TSHR (0.43) TSHRLMNAALDH1A1THRBSMN1; SMN2
SCHEMBL702940 0.92 TSHR (0.43) TSHRLMNAALDH1A1THRBSMN1; SMN2
Fluoride SCHEMBL27639893 0.92 TSHR (0.43) TSHRLMNAALDH1A1THRBSMN1; SMN2
SCHEMBL10423271 0.92 TSHR (0.43) TSHRLMNAALDH1A1THRBSMN1; SMN2
SCHEMBL16497147 0.89 TSHR (0.47) TSHRLMNAALDH1A1THRBSMN1; SMN2
SCHEMBL10415307 0.89 TSHR (0.40) TSHRLMNAALDH1A1THRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906682-B2 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY (US) 2011-03-15 US disclosed
US-20100108230-A1 SYNTHESIS OF SOLUBLE FUNCTIONALIZED LITHIUM INITIATORS THE GOODYEAR TIRE & RUBBER COMPANY (US) 2010-05-06 US disclosed
US-7671237-B2 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY (US) 2010-03-02 US disclosed
US-7166747-B2 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY (US) 2007-01-23 US disclosed
US-20060252861-A1 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY (US) 2006-11-09 US disclosed
US-20040097634-A1 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY 2004-05-20 US disclosed
US-6686504-B2 COMPLEX POLYMERIZATION CATALYST THE GOODYEAR TIRE & RUBBER COMPANY 2004-02-03 US disclosed
US-6518214-B2 Organolithium compounds; soluble in aromatic hydrocarbons THE GOODYEAR TIRE & RUBBER COMPANY 2003-02-11 US disclosed
US-20020035294-A1 Synthesis of soluble functionalized lithium initiators GOODYEAR TIRE & RUBBER COMPANY, THE 2002-03-21 US disclosed
US-20020019551-A1 Synthesis of functionalized lithium initiator GOODYEAR TIRE & RUBBER COMPANY, THE 2002-02-14 US disclosed
US-4128606-A Impact-resistant chemically blended propylene polymer composition and process for preparation thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1978-12-05 US disclosed
US-4071672-A COMPLEX CATALYST MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) 1978-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097634-A1 Synthesis of soluble functionalized lithium initiators KDM5B, KDM2B, KDM5A TSHR 2536/4885LMNA 295/4885ALDH1A1 271/4885
US-20020019551-A1 Synthesis of functionalized lithium initiator KCNMB1, TRPA1, KCNMB4 TSHR 2600/4885LMNA 276/4885ALDH1A1 1843/4885
US-20020035294-A1 Synthesis of soluble functionalized lithium initiators KDM5B, KDM2B, KDM5A TSHR 2535/4885LMNA 298/4885ALDH1A1 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.